Basic Information
CureTech is a biotechnology company developing an immunotherapy treatment for cancer, which has successfully advanced to late-stage clinical trials and is specifically designed to treat BIPG (a rare type of brain tumor).
CureTech Ltd.
Israel
15~50 people
January 01, 2001
--
uretech@curetechbio.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios